Device Trial Radar · NCT06358001
EchoTip AcuCore Post-Market Clinical Study
Last checked: Nov 19, 2026Latest source record: Sep 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
183
Actual
Start
Aug 5, 2024
Primary completion
Jun 14, 2025
Study completion Jul 19, 2025
Sponsor
- Lead sponsor
- Cook Research IncorporatedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 10, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of collecting this data is to continue to learn more about the EchoTip AcuCore and the device's ability to produce the desired favorable effect and if there are any undesired outcomes that may be related to the EchoTip AcuCore.
Conditions
- Adenocarcinoma
- Neuroendocrine Tumors
- Hepatocellular Carcinoma
- Cholangiocarcinoma
- Malignant Lymphoma
- Metastasis
- Chronic Pancreatitis
- Autoimmune Pancreatitis
Interventions
EchoTip AcuCoreDevice
Using endoscopic ultrasound guided needle to collect biopsies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Technical SuccessTime frame: Duration of the procedure (approx. 1 hr)
Locations
8 sites in 1 country. Site status is shown where the registry gives one.
University of California, Irvine
Orange, California
Advent Health, Porter
Denver, Colorado
Shands Hospital-University of Florida
Gainesville, Florida
5 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.